HilleVax
About:
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
Website: https://www.hillevax.com/
Twitter/X: HilleVax
Top Investors: RA Capital Management, Lightspeed Venture Partners, Deerfield, Perceptive Advisors, Samsara BioCapital
Description:
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.
Total Funding Amount:
$235M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2021-01-01
Contact Email:
info(AT)hillevax.com
Founders:
David Socks, Robert M. Hershberg
Number of Employees:
101-250
Last Funding Date:
2023-09-19
IPO Status:
Public
Industries:
© 2025 bioDAO.ai